Literature DB >> 21948613

Concise review: The magic act of generating induced pluripotent stem cells: many rabbits in the hat.

Gustavo Mostoslavsky1.   

Abstract

Since the seminal discovery by Yamanaka et al. demonstrating that four transcription factors were capable of inducing nuclear reprogramming to a pluripotent state, a plethora of publications have followed aimed at improving the efficiency, simplicity, and safety of the original methodology that was based on the use of integrating retroviruses. A better understanding of the basic mechanisms behind reprogramming as well as an improvement in tissue culture conditions have allowed for the development of new tools based on different molecular approaches, such as excisable and nonintegrating vectors, RNA, proteins, and small compounds, among others. In most instances, a dynamic interplay exists between each method's efficiency of reprogramming versus overall safety, and these points need to be considered when choosing a particular approach. Regardless, the fast pace at which this field has advanced in recent years attracted many investigators to enter into the induced pluripotent stem cell (iPSC) world and has made the process of nuclear reprogramming and iPSC generation a routine lab technique.
Copyright © 2011 AlphaMed Press.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21948613     DOI: 10.1002/stem.742

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  5 in total

1.  Derivation and characterization of a transgene-free human induced pluripotent stem cell line and conversion into defined clinical-grade conditions.

Authors:  Jason P Awe; Agustin Vega-Crespo; James A Byrne
Journal:  J Vis Exp       Date:  2014-11-26       Impact factor: 1.355

Review 2.  Ophthalmologic stem cell transplantation therapies.

Authors:  Timothy A Blenkinsop; Barbara Corneo; Sally Temple; Jeffrey H Stern
Journal:  Regen Med       Date:  2012-11       Impact factor: 3.806

3.  New directions in cellular therapy of cancer: a summary of the summit on cellular therapy for cancer.

Authors:  David F Stroncek; Carolina Berger; Martin A Cheever; Richard W Childs; Mark E Dudley; Peter Flynn; Luca Gattinoni; James R Heath; Michael Kalos; Francesco M Marincola; Jeffrey S Miller; Gustavo Mostoslavsky; Daniel J Powell; Mahendra Rao; Nicholas P Restifo; Steven A Rosenberg; John O'Shea; Cornelis J M Melief
Journal:  J Transl Med       Date:  2012-03-15       Impact factor: 5.531

4.  Advancements in Induced Pluripotent Stem Cell Technology for Cardiac Regenerative Medicine.

Authors:  Carol Y Suh; Zelun Wang; Oscar Bártulos; Yibing Qyang
Journal:  J Cardiovasc Pharmacol Ther       Date:  2014-03-19       Impact factor: 2.807

5.  Genetic reprogramming of human amniotic cells with episomal vectors: neural rosettes as sentinels in candidate selection for validation assays.

Authors:  Patricia G Wilson; Tiffany Payne
Journal:  PeerJ       Date:  2014-11-18       Impact factor: 2.984

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.